Classifields ads

bg
BNY hires Phillip Suh as Korea country manager

BNY hires Phillip Suh as Korea country manager

Phillip Suh, previously CEO at Samsung Asset Management, will replace the retiring...

bg
Asia to see mixed activity in 2026: banks

Asia to see mixed activity in 2026: banks

Amid a trade slowdown, IPOs, the issuance of convertible bonds, and cross-border...

bg
Global Infrastructure Partners invests in Philippines’ Aboitiz InfraCapital

Global Infrastructure Partners invests in Philippines’...

Philippines’ Aboitiz Equity Ventures has agreed for BlackRock's Global Infrastructure...

bg
Ryan Ellis named Citi Australia, NZ head of markets sales

Ryan Ellis named Citi Australia, NZ head of markets sales

Sydney-based Ellis has been leading the Australia & New Zealand rates sales...

bg
FinanceAsia wishes our readers a restful holiday season

FinanceAsia wishes our readers a restful holiday season

FinanceAsia wishes our readers a restful holiday season. FA will have a limited...

bg
Deal Analysis: Syfe's acquisition of Australia's Selfwealth

Deal Analysis: Syfe's acquisition of Australia's...

Samantha Horton, group chief operating officer and head of international at Syfe,...

bg
Societe Generale appoints head of global markets in Apac

Societe Generale appoints head of global markets in Apac

Mohamed Braham will assume the role, while retaining his position as deputy global...

bg
Societe Generale appoints head of global markets in Apac

Societe Generale appoints head of global markets in Apac

Mohamed Braham will assume the role, while retaining his position as deputy global...

bg
Singapore's Sembcorp Industries to buy Alinta Energy from Chow Tai Fook Enterprises for A$6.5bn

Singapore's Sembcorp Industries to buy Alinta Energy...

Alinta Energy is one of Australia’s leading energy retailers and generators. Sembcorp...

bg
Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence deal

Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence...

YP05002, developed by Yao Pharma, is in Phase 1 clinical development in Australia...